Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY23 results · Apr–Jun 2022
Metropolis Healthcare reported revenue from operations of ₹279.86 crore (down 14.4% from Q1 FY22) and net profit of ₹33.56 crore (down 55.2% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 279.86 | 326.76 | −14.4% | 305.90 | −8.5% |
| Other income | 3.04 | 3.76 | −19.3% | 5.68 | −46.5% |
| Total income | 282.90 | 330.53 | −14.4% | 311.58 | −9.2% |
| Profit before tax | 42.83 | 103.08 | −58.5% | 56.47 | −24.2% |
| Net profit for the period | 33.56 | 74.92 | −55.2% | 40.15 | −16.4% |
| Attributable to shareholders of the company | 33.40 | 74.89 | −55.4% | 39.99 | −16.5% |
| EPS, basic (₹) | 6.53 | 14.65 | −55.4% | 7.81 | −16.4% |
| Net margin (%) | 12.0 | 22.9 | 13.1 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 257.02 | 264.10 | −2.7% | 261.05 | −1.5% |
| Other income | 2.42 | 3.28 | −26.0% | 5.73 | −57.7% |
| Total income | 259.44 | 267.38 | −3.0% | 266.78 | −2.7% |
| Profit before tax | 35.58 | 81.73 | −56.5% | 46.29 | −23.2% |
| Net profit for the period | 28.38 | 59.52 | −52.3% | 33.08 | −14.2% |
| EPS, basic (₹) | 5.54 | 11.64 | −52.4% | 6.47 | −14.4% |
| Net margin (%) | 11.0 | 22.5 | 12.7 |
Consolidated
- Filed with BSE
- 12 Aug 2022, 11:31 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Aug 2022, 11:31 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE